GaëlSaint Olive

Partner

Paris + 33.1.56.59.39.39

Gaël Saint Olive advises French and foreign clients in international mergers and acquisitions and joint ventures, including multijurisdictional transactions involving coordination of legal teams in multiple countries.

He advised Sanofi in the creation of a joint venture with Lonza, the dismantlement of its European joint venture with Merck & Co. pertaining to vaccines, the sale of research sites and related research partnership and IP licenses to Evotec AG, the sale of various worldwide or multinational pharmaceutical businesses and of an African subsidiary, the acquisition of a leading generics manufacturer in Colombia, and the acquisition of pharmaceutical assets in Africa.

Other representative clients include: Solvay in the sale of one of its European divisions to Imerys; Simon Property Group in the acquisition of a 27.8 percent interest in Klépierre; Société de Financement Local (SFIL) in its creation as part of the market withdrawal of Dexia Crédit Local; and Caisse des Dépôts et Consignations in connection with several public-private partnerships and the High Museum in Atlanta in its partnership with Musée du Louvre.

Gaël is the Administrative Partner of the Firm's Paris Office.

Experience

  • Sanofi sells infectious disease unit to EvotecJones Day advised Sanofi in the sale of its infectious disease unit to Evotec AG.
  • Sanofi sells over-the-counter portfolio to Charterhouse for €158 million (US$195 million)Jones Day advised Sanofi SA in its €158 million (US$195 million) sale of a portfolio of 12 over-the-counter pharmaceuticals products to an affiliate of the Cooper-Vemedia group, a subsidiary of Charterhouse Capital Partners LLP group.
  • Vivendi sells stake in Ubisoft Entertainment for approximately €2 billionJones Day advised Crédit Agricole Corporate and Investment Bank (CACIB) in connection with the sale by Vivendi of its stake in Ubisoft Entertainment (Ubisoft) for approximately €2 billion.
  • Campus Agro leads AgroParisTech-INRA campus project in SaclayJones Day advised Caisse des Depots et Consignations (CDC), as shareholder of Campus Agro SAS (a company created by AgroParisTech, INRA, and CDC), on a project including (i) a public-public partnership and (ii) a public-private partnership (€257 million) lasting for 30 years with a consortium led by GTM Bâtiment (VINCI group) and ENGIE Cofely. The consortium will design, build, maintain, and operate the new AgroParisTech-INRA campus in Saclay.
  • Sanofi and Lonza form joint venture to establish large-scale biologics production facility in SwitzerlandJones Day advised Sanofi in the formation of a joint venture with Lonza Group AG to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.
  • Sanofi dissolves joint venture with MerckJones Day advised Sanofi in the dissolution of a 22 year old pan European joint venture with Merck & Co.
  • Henderson Park buys Le Méridien Etoile Hotel, the largest hotel in Paris, for €365 million (US$392 million)Jones Day advised Henderson Park Real Estate Fund I on its acquisition and first mortgage financing of Le Méridien Etoile Hotel, the largest hotel in Paris, which was sold by a partnership of Mount Kellett Capital Management and Cedar Capital Partners, for €365 million (US$392 million).
  • Atlas Holdings completes first phase of purchase of NCR Corporation's Interactive Printer Solutions DivisionJones Day represented affiliates of Atlas Holdings, LLC in its acquisition of the Interactive Printer Solutions ("IPS") division of NCR Corporation.
  • Solvay divests its PCC business to ImerysJones Day advised Solvay in the divestiture of its PCC (precipitated calcium carbonates) business to Imerys.
  • Cardinal Health acquires Cordis for $1.9 billionJones Day advised Cardinal Health, Inc. in its acquisition of Johnson & Johnson's Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.9 billion in cash.
  • Sanofi sells research site in Toulouse to EvotecJones Day advised Sanofi in the sale of a research site in Toulouse, France to Evotec as part of a strategic partnership according to which Sanofi granted a €250 million (US$270 million) commitment over a period of five years, dedicated to the setting up of a joint research and development program of the activity of the research and development platforms of the site in Toulouse.
  • Sanofi acquires leading Colombia pharmaceuticals manufacturer GenfarJones Day advised Sanofi in the acquisition of Genfar S.A., a leading pharmaceuticals manufacturer headquartered in Bogota, Colombia.
  • Société de Financement Local created and related transfer of Dexia Municipal Agency in connection with market withdrawal of DexiaJones Day served as counsel to Société de Financement Local (SFIL), a newly created credit institution approved by the Autorité de contrôle prudentiel and owned by each of the French State; Caisse des dépôts et consignations (CDC); and La Banque Postale (LBP); in connection with the response to the structural financing difficulties encountered by the local public sector following the withdrawal of Dexia SA from the public market.
  • Sanofi acquires African pharmaceutical assets of Medreich Ltd.Jones Day advised Sanofi in the acquisition of African pharmaceutical assets of Medreich Ltd.
  • Simon Property Group completes acquisition of 28.7% interest in KlépierreJones Day advised Simon Property Group, Inc. in the $2 billion acquisition of a 28.7% equity stake in Klépierre, a listed French real estate company (SIIC), from the French bank BNP Paribas.
  • Sanofi sells Dermik dermatology unit to Valeant Pharmaceuticals for $425 millionJones Day advised Sanofi in the sale of its Dermik dermatology unit to Valeant Pharmaceuticals International Inc. for $425 million.
  • CIBAIR sponsors Internet Protocol Network project for French airforceJones Day acted as counsel to the successful consortium for the €87 million (US$126 million) project financing for the design, construction, maintenance, rollout, management, and support of the telecommunications network under the Internet Protocol on all French Air Force bases.
  • Caisse des Dépôts et Consignations participates in €1 billion (US$1.4 billion) French Pentagon PPP agreementJones Day advised Caisse des Dépôts et Consignations in connection with the negotiation of a public-private-partnership (PPP) agreement with the French Ministry of Defense for a project considered to be the most important "building oriented" PPP ever developed in France.
  • Lagardère Services extends joint venture with Aéroports de Paris concerning retail operations in Parisian airportsJones Day advised Lagardère Services in extending its joint venture with Aéroports de Paris concerning alcohol, tobacco, perfume, cosmetics, and food retail activities in the Paris Charles de Gaulle and Paris Orly airports.
  • Simon Property Group sells Simon Ivanhoe to Unibail-Rodamco for €715 million ($978 million)Jones Day advised Simon Property Group, Inc. in its €715 million ($978 million) sale of Simon Ivanhoe to Unibail-Rodamco, including a joint venture agreement to retain 50% of Simon Ivanhoe's interests in five retail development projects in France.
  • Additional Publications

    • March 20, 2006
      Dépénalisation, vous avez dit dépénalisation ?, Option Finance

    Speaking Engagements

    • 12 avril 2018
      Finale de la 4ème édition du Prix Jones Day/Paris II/ESSEC
    • 20 avril 2017
      Finale de la 3ème édition du Prix Jones Day/ESSEC/Paris II
    • 24 mai 2016
      Réforme du droit des contrats et du droit des obligations - 1er volet : quel impact pour vos opérations M&A ?
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.